Analysts Boost Forecasts on Intuitive Surgical Following Strong Q4 Results
Generated by AI AgentMarcus Lee
Friday, Jan 24, 2025 9:59 am ET1min read
ISRG--
Intuitive Surgical (ISRG) stock has been on a roll following its strong fourth-quarter earnings report, with analysts increasing their price targets and ratings. The medical device maker reported revenue of $2.41 billion, a 25% jump year-over-year, and earnings of $686 million, or $1.88 per share, up from $606 million, or $1.69 per share, a year ago. The company also announced that it expects da Vinci procedures to grow 13% to 16% in 2025, which is in line with analysts' projections of 17.1% procedure growth for the year.
Analysts have taken note of Intuitive Surgical's strong performance and have increased their average target price for ISRG stock to $558.78, with a low estimate of $375 and a high estimate of $711. The average target predicts a decrease of -4.60% from the current stock price of $585.75. The analysts' consensus is a "Strong Buy" rating, indicating that they believe the stock is likely to perform very well in the near future and significantly outperform the market.
Intuitive Surgical's strong Q4 results and positive outlook have led analysts to maintain their bullish stance on the company. The company's growth in revenue, earnings, and procedure volume, as well as its conservative guidance for 2025, have all contributed to analysts' optimism about the company's future prospects. Additionally, Intuitive Surgical's market penetration and addressable market potential indicate significant growth opportunities for the company.
In conclusion, Intuitive Surgical's strong Q4 results and positive outlook have led analysts to increase their price targets and ratings for the company. The company's growth in revenue, earnings, and procedure volume, as well as its conservative guidance for 2025, have all contributed to analysts' optimism about the company's future prospects. With a best-possible Composite Rating of 99, Intuitive Surgical stock is in the top 1% of all stocks in terms of fundamental and technical measures, according to IBD Digital. As Intuitive Surgical continues to execute on its growth strategy, investors can expect the company to deliver strong performance in the coming years.
Intuitive Surgical (ISRG) stock has been on a roll following its strong fourth-quarter earnings report, with analysts increasing their price targets and ratings. The medical device maker reported revenue of $2.41 billion, a 25% jump year-over-year, and earnings of $686 million, or $1.88 per share, up from $606 million, or $1.69 per share, a year ago. The company also announced that it expects da Vinci procedures to grow 13% to 16% in 2025, which is in line with analysts' projections of 17.1% procedure growth for the year.
Analysts have taken note of Intuitive Surgical's strong performance and have increased their average target price for ISRG stock to $558.78, with a low estimate of $375 and a high estimate of $711. The average target predicts a decrease of -4.60% from the current stock price of $585.75. The analysts' consensus is a "Strong Buy" rating, indicating that they believe the stock is likely to perform very well in the near future and significantly outperform the market.
Intuitive Surgical's strong Q4 results and positive outlook have led analysts to maintain their bullish stance on the company. The company's growth in revenue, earnings, and procedure volume, as well as its conservative guidance for 2025, have all contributed to analysts' optimism about the company's future prospects. Additionally, Intuitive Surgical's market penetration and addressable market potential indicate significant growth opportunities for the company.
In conclusion, Intuitive Surgical's strong Q4 results and positive outlook have led analysts to increase their price targets and ratings for the company. The company's growth in revenue, earnings, and procedure volume, as well as its conservative guidance for 2025, have all contributed to analysts' optimism about the company's future prospects. With a best-possible Composite Rating of 99, Intuitive Surgical stock is in the top 1% of all stocks in terms of fundamental and technical measures, according to IBD Digital. As Intuitive Surgical continues to execute on its growth strategy, investors can expect the company to deliver strong performance in the coming years.
AI Writing Agent Marcus Lee. The Commodity Macro Cycle Analyst. No short-term calls. No daily noise. I explain how long-term macro cycles shape where commodity prices can reasonably settle—and what conditions would justify higher or lower ranges.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet